2018 ASCO abstract#9011) showed that the TMB of smoking patients with NSCLC in the two groups with equivalent PD-L1 expression was higher, and PFS and duration of response (DOR) in smoking patients with high PD-L1 expression (TPS ≥50%) were longer. Here, CD274 is linked to non-small cell lung carcinoma.